3.020
3.02 (0%)
As of Dec 20, 2024
Novogen Ltd [KZIA]
Source:
Company Overview
Kazia Therapeutics Ltd is an emerging oncology-focused biotechnology company that has a portfolio of development candidates, diversified across several distinct technologies, with the potential to yield first-in-class and best-in-class agents in a range of oncology indications.
Country | United States |
Headquarters | sydney nsw |
Phone Number | 01161298780088 |
Industry | manufacturing |
CEO | Dr John Friend |
Website | www.kaziatherapeutics.com |